Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Questionnaire survey on severe hypoglycemia in pediatric patients with diabetes-English version.
Urakami T, Hotsubo T, Ogawa Y, Kikuchi T, Usuda R, Matsui K, Hirose M, Hirai H, Abiru N, Fujiwara I, Mizuno H, Miyako K, Takahashi K, Shimada A; Committee of Pediatric Diabetes in the Japan Diabetes Society. Urakami T, et al. Diabetol Int. 2024 Aug 15;15(4):666-672. doi: 10.1007/s13340-024-00742-5. eCollection 2024 Oct. Diabetol Int. 2024. PMID: 39469563
Nonfullerene Acceptors Bearing Spiro-Substituted Bithiophene Units in Organic Solar Cells: Tuning the Frontier Molecular Orbital Distribution to Reduce Exciton Binding Energy.
Wang K, Jinnai S, Urakami T, Sato H, Higashi M, Tsujimura S, Kobori Y, Adachi R, Yamakata A, Ie Y. Wang K, et al. Among authors: urakami t. Angew Chem Int Ed Engl. 2024 Nov 18;63(47):e202412691. doi: 10.1002/anie.202412691. Epub 2024 Oct 15. Angew Chem Int Ed Engl. 2024. PMID: 39133206
A highly selective KIT inhibitor MOD000001 suppresses IgE-mediated mast cell activation.
Nakamura Y, Urakami T, Ishimaru K, Vuong Tran NQ, Shimizu T, Sinko W, Takahashi T, Marappan S, Narayanan K, Poddutoori R, Terada Y, Nakao A. Nakamura Y, et al. Among authors: urakami t. J Allergy Clin Immunol Glob. 2024 Apr 3;3(3):100249. doi: 10.1016/j.jacig.2024.100249. eCollection 2024 Aug. J Allergy Clin Immunol Glob. 2024. PMID: 38764489 Free PMC article.
A multicenter, open-label, single-arm trial of the long-term safety of empagliflozin treatment for refractory diabetes mellitus with insulin resistance (EMPIRE-02).
Hirota Y, Kakei Y, Imai J, Katagiri H, Ebihara K, Wada J, Suzuki J, Urakami T, Omori T, Ogawa W. Hirota Y, et al. Among authors: urakami t. J Diabetes Investig. 2024 Sep;15(9):1211-1219. doi: 10.1111/jdi.14226. Epub 2024 May 4. J Diabetes Investig. 2024. PMID: 38702973 Free PMC article. Clinical Trial.
235 results